Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Intellia Therapeutics, Inc. (NTLA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/25/2023 |
SC 13G
| BlackRock Inc. reports a 8.7% stake in Intellia Therapeutics, Inc. |
| 02/09/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/09/2019 |
SC 13G
| Nikko Asset Management Americas, Inc. reports a 11.3% stake in INTELLIA THERAPEUTICS, INC. |
| 07/09/2019 |
SC 13G
| Sumitomo Mitsui Trust Holdings, Inc. reports a 11.3% stake in Intellia Therapeutics, Inc. |
| 02/14/2019 |
SC 13G
| ARK Investment Management LLC reports a 15.7% stake in Intellia Therapeutics, Inc. |
| 02/13/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/11/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/07/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/28/2017 |
SC 13G
| Caribou Biosciences, Inc. reports a 15.5% stake in Intellia Therapeutics, Inc. |
| 02/09/2017 |
SC 13G
| Atlas Venture Fund IX, L.P. reports a 12.3% stake in INTELLIA THERAPUTICS, INC. |
| 06/10/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 05/11/2016 |
SC 13G
| Intellia Therapeutics, Inc. reports a 7.7% stake in Intellia Therapeutics, Inc. |
|
|